All times are listed in CET (Central European Time)

Browsing Over 190 Presentations

Sort By
Lung cancer screening: The end of the beginning Educational session

Implementation of screening programmes

Lecture Time
10:15 - 10:30
Speakers
  • S. Couraud (Lyon, France)
Session Name
Lung cancer screening: The end of the beginning
Room
Channel 1
Date
Thu, 25.03.2021
Time
10:00 - 11:00
Authors
  • S. Couraud (Lyon, France)
Mesothelioma: Will I-O shape the future? Educational session

Indication for lung-sparing radiotherapy

Lecture Time
10:30 - 10:45
Speakers
  • A. Rimner (New York, NY, United States of America)
Session Name
Mesothelioma: Will I-O shape the future?
Room
Channel 3
Date
Thu, 25.03.2021
Time
10:00 - 11:00
Authors
  • A. Rimner (New York, NY, United States of America)
Novel therapeutic approaches: Exciting times in lung cancer Educational session

New approaches in supportive care

Lecture Time
10:45 - 11:00
Speakers
  • K. Jordan (Heidelberg, Germany)
Session Name
Novel therapeutic approaches: Exciting times in lung cancer
Room
Channel 2
Date
Thu, 25.03.2021
Time
10:00 - 11:00
Authors
  • K. Jordan (Heidelberg, Germany)
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Role of chemo-free combinations

Lecture Time
11:35 - 11:50
Speakers
  • S. Ramalingam (Atlanta, GA, United States of America)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • S. Ramalingam (Atlanta, GA, United States of America)
The eternal debate in stage III Multidisciplinary Tumour Board

What is the best local treatment? Radiation therapy

Lecture Time
11:35 - 11:50
Speakers
  • M. Werner-Wasik (Philadelphia, PA, United States of America)
Session Name
The eternal debate in stage III
Room
Channel 2
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • M. Werner-Wasik (Philadelphia, PA, United States of America)
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Presentation of case: Monotherapy or chemoimmunotherapy in PD-L1>50%?

Lecture Time
11:15 - 11:20
Speakers
  • L. Landi (Ravenna, Italy)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • L. Landi (Ravenna, Italy)
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start? Young oncologists

Your perspective and personal story

Lecture Time
11:43 - 11:49
Speakers
  • F. Blackhall (Manchester, United Kingdom)
Session Name
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start?
Room
Channel 3
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • F. Blackhall (Manchester, United Kingdom)
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Q&A and live discussion

Lecture Time
12:20 - 12:35
Speakers
  • A. Speakers (, Switzerland)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • A. Speakers (, Switzerland)
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start? Young oncologists

Your perspective and personal story

Lecture Time
11:25 - 11:31
Speakers
  • J. Wolf (Köln, Germany)
Session Name
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start?
Room
Channel 3
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • J. Wolf (Köln, Germany)
The eternal debate in stage III Multidisciplinary Tumour Board

Q&A and live discussion

Lecture Time
12:20 - 12:35
Speakers
  • A. Speakers (, Switzerland)
Session Name
The eternal debate in stage III
Room
Channel 2
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • A. Speakers (, Switzerland)
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start? Young oncologists

Your perspective and personal story

Lecture Time
11:31 - 11:37
Speakers
  • L. Paz-Ares (Madrid, Spain)
Session Name
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start?
Room
Channel 3
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • L. Paz-Ares (Madrid, Spain)
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Role of chemo-IO combinations

Lecture Time
11:50 - 12:05
Speakers
  • F. Cappuzzo (Rome, NY, Italy)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • F. Cappuzzo (Rome, NY, Italy)